| Name | Solanezumab |
|---|
| Description | Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |